UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: european union

The future of GMOs, gene editing and plant biotechnology in post-Brexit UK

Growing and selling genetically modified organisms (GMOs) is permitted in the UK but GMO products are subject to a lengthy and stringent EU authorization process. There are currently no GM crops grown commercially in the UK, but they are imported. So, what is the UK’s relationship with GM products, and where do we stand on gene editing? We spoke with Nigel Halford, Principal Research Scientist at Rothamsted Research, UK.

Read More

The Plant Genomics and Gene Editing Congress Presentation Slides

Following the Plant Genomics and Gene Editing Congress: Europe, we have made the following presentation slides from Ana Atanassova, Ian Bancroft, Nigel Halford and Kim Hammond-Kossack available.

Read More

Navigating the European Court of Justice stance on GMOs

“The breeder’s dream is, of course, of an agency which would enable him to produce at will a particular kind of mutation uncontaminated by others which would merely be a nuisance to him….”

“There is as yet no indication from genetics of how, or even whether, this could be done… The dream of directed mutation as a tool in stock and crop improvement is still very much a dream”

These words were part of a lecture given by the well-known geneticist Kenneth Mather at the John Innes Institute in 1960. Now, after more than 50 years of research, his dream of directed mutation has become a reality.

Read More

To regulate or not to regulate: Current legal status for gene-edited crops

Gene editing is the latest and sexiest DNA editing tool in the continuum of plant breeding innovations. With genetically modified organism (GMO) technology, scientists introduce “foreign” genes, i.e. genes from a different organism, into crops. With gene editing, scientists create additional genetic variation by making precise changes to the existing crop’s genome. It offers great opportunities, but also creates regulatory challenges.

Read More

When Blockchain Meets the Right to be Forgotten: Technology Versus Law

Over the past few years, the popularity of the blockchain and cryptocurrencies has increased and has reached important notoriety, not only in scientific and IT journals, but also in the media. Although there are many kinds of cryptocurrencies in circulation nowadays, the most popular is Bitcoin.

Read More

The Microbiome Represents a Paradigm Shift for European Pharmaceutical Regulators

Recent microbiome research has demonstrated the important role that these communities of microorganisms play on human homeostasis. The gut microbiome is being thoroughly studied, and other microbiomes are now becoming the focus of greater attention, as well as other organs of the host, due to the concept of ‘axes,’ such as the gut-brain axis, gut-lung axis, gut-liver axis.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive